Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • The Dose (New Items)
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

MAPS Statement on Trauma and Crisis Response in Palestine and Israel

Many in the MAPS community are grieving the loss and suffering experienced by family, friends, colleagues, and countless others impacted by the Israel-Hamas war. At MAPS, we have been in deep dialogue …
October 19, 2023

PS2023: The Virtual Trip Unveils Latest Video Release Featuring Michael Pollan, Melissa Etheridge, and More

PS2023: The Virtual Trip, produced by the Multidisciplinary Association for Psychedelic Studies (MAPS), has published an additional 40 session videos from Psychedelic Science 2023, showcasing a trove of …
October 9, 2023

MAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD

FOR IMMEDIATE RELEASE: September 14, 2023 Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder, MAPP2, have been published in Nature Medicine. MAPP2 …
September 13, 2023

MAPS Launches Online Video Sessions from Psychedelic Science 2023 with The Virtual Trip

The Multidisciplinary Association for Psychedelic Studies (MAPS) has begun publishing a collection of content from the highly acclaimed Psychedelic Science 2023 conference. PS2023: The Virtual Trip brings …
August 30, 2023

FDA Division of Pulmonology, Allergy, and Critical Care Provides Additional Guidance on Phase 2 Study of Cannabis for Veterans with PTSD (MJP2)

On August 11, the FDA Division of Pulmonology, Allergy, and Critical Care (DPACC) sent MAPS additional guidance on the safety of smoking in naïve subjects in MJP2. The FDA’s correspondence was a …
August 11, 2023

FDA Sends the Official Minutes of Type A Meeting for Phase 2 Study of Cannabis for Veterans with PTSD (MJP2)

On July 12, 2023, the FDA Division of Psychiatry sent MAPS the official minutes of our Type A meeting on June 15, 2023. The Type A meeting focused on the issues the FDA cited in its Clinical Hold on the …
July 12, 2023

MAPS Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation

MAPS and the Steven & Alexandra Cohen Foundation Partner to Support the Development of Psychedelic-Assisted Therapies FOR IMMEDIATE RELEASE: June 22, 2023 TheMultidisciplinary Association for Psychedelic …
June 22, 2023

Former Texas Governor Rick Perry to Speak at Psychedelic Science 2023

Texas’ Longest Serving Governor and Advocate for Psychedelic Medicine Will Help Kick off the Largest Psychedelic Conference Psychedelic Science 2023, the breakthrough psychedelic conference hosted by …
June 15, 2023

Jaden Smith to Speak at World’s Largest Psychedelic Science Conference

Multi-hyphenate entertainer, entrepreneur, advocate, and musician to speak about psychedelic medicine, healing, and mental health Psychedelic Science 2023, the breakthrough psychedelic conference hosted …
June 14, 2023

Colorado Governor Jared Polis Named Opening Speaker for Psychedelic Science 2023

Governor Polis to kick off the world’s largest gathering of the psychedelic ecosystem in Denver Psychedelic Science 2023, the breakthrough psychedelic conference hosted by Multidisciplinary Association …
June 9, 2023

MAPS-Sponsored Global Psychedelic Survey Gathers Data for a Crucial View into Psychedelic Use 

FOR IMMEDIATE RELEASE: May 22, 2023 The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the launch of the Global Psychedelic Survey. Co-sponsored by MAPS, SABI Mind, Mind Medicine …
May 22, 2023

Psychedelic Science 2023 Announces Sessions and Select Featured Speakers for the Therapy and Practitioners Tracks for June Conference

Today, Psychedelic Science 2023, the breakthrough psychedelic conference hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by Momentum Events, announced its sessions …
May 12, 2023

Posts pagination

Newer Posts Page 1 … Page 8 … Page 299 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Designed with WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide